Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis?

Gallagher, 1973, Oestrogens and calcium-metabolism, Vol. 2, 98 Recker, 1977, Effect of estrogens and calcium carbonate on bone loss in postmenopausal women, Ann Intern Med, 87, 649, 10.7326/0003-4819-87-6-649 Nachtigall, 1979, Estrogen replacement therapy I: A 10-year prospective study in the relationship to osteoporosis, Obstet Gynecol, 53, 277 Lindsay, 1980, Prevention of spinal osteoporosis in oophorectomised women, Lancet, ii, 1151, 10.1016/S0140-6736(80)92592-1 Christiansen, 1981, Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy, Lancet, i, 459, 10.1016/S0140-6736(81)91848-1 Quigley, 1987, Estrogen therapy arrests bone loss in elderly women, Am J Obstet Gynecol, 156, 1516, 10.1016/0002-9378(87)90025-1 Hutchinson, 1979, Postmenopausal oestrogens protect against fractures of hip and distal radius, Lancet, ii, 705, 10.1016/S0140-6736(79)90640-8 Weiss, 1980, Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen, N Engl J Med, 303, 1195, 10.1056/NEJM198011203032102 Paganini-Hill, 1981, Menopausal estrogen therapy and hip fractures, Ann Intern Med, 95, 28, 10.7326/0003-4819-95-1-28 Kiel, 1987, Hip fracture and the use of estrogens in postmenopausal women. The Framingham study, N Engl J Med, 317, 1169, 10.1056/NEJM198711053171901 Ettinger, 1985, Long-term estrogen replacement therapy prevents bone loss and fractures, Ann Intern Med, 102, 319, 10.7326/0003-4819-102-3-319 Christiansen, 1990, 17-β estradiol and continuous norethisterone: A unique treatment for established osteoporosis in elderly women, J Clin Endocrinol Metab, 71, 836, 10.1210/jcem-71-4-836 Frost, 1984, The origin and nature of transients in human bone remodelling dynamics, 124 Riggs, 1972, Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis, J Clin Invest, 51, 1659, 10.1172/JCI106967 Chesnut, 1983, Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action, Metabolism, 32, 371, 10.1016/0026-0495(83)90027-6 Need, 1989, Crossover study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis, Bone, 10, 3, 10.1016/8756-3282(89)90139-7 Need, 1989, Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women, Arch Intern Med, 149, 57, 10.1001/archinte.1989.00390010075007 Dequeker, 1985, Anabolic steroids and osteoporosis, Acta Endocrinol, 45, 10.1530/acta.0.109S0045 Geusens, 1986, Long-term effect of nandrolone decanoate, 1α-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study, Bone Miner, 1, 347 Johansen, 1989, Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?, Bone Miner, 6, 77, 10.1016/0169-6009(89)90025-1 Adami, 1987, The low osteocalcin level of glucocorticoid treated patients can be brought to normal by nandrolone decanoate administration, 1039 Hassager, 1990, Type I and type III collagen production in osteoporotic women during estrogen/progestagen substitution and anabolic steroid therapy, J Bone Miner Res, 5, S116 Eriksen, 1988, Evidence of estrogen receptors in normal human osteoblast-like cells, Science, 241, 84, 10.1126/science.3388021 Colvard, 1989, Identification of androgen receptors in normal human osteoblast-like cells, 86, 854 van Berkum, 1988, Peripheral and axial bone mass in Dutch women, Relationship to age and menopausal state, Neth J Med, 32, 226 Nilas, 1985, Comparison of single- and dual-photon absorptiometry in postmenopausal bone mineral loss, J Nucl Med, 26, 1257 Krolner, 1980, Measurement of bone mineral content (BMC) of the lumbar spine I. Theory and application of a new two-dimensional dual-photon attenuation method, Scand J Lab Clin Invest, 40, 653, 10.3109/00365518009091978 van Berkum, 1989, Non-invasive axial and peripheral assessment of bone mineral content: a comparison between csteoporotic women and normal subjects, J Bone Miner Res, 4, 679, 10.1002/jbmr.5650040506 Storm, 1990, Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis, N Engl J Med, 322, 1265, 10.1056/NEJM199005033221803 Reeve, 1980, Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial, Br Med J, 280, 1340, 10.1136/bmj.280.6228.1340 Hodsman, 1991, Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1–38) and salmon calcitonin in osteoporotic patients, Bone Miner, 14, 67, 10.1016/0169-6009(91)90103-7 Birkenhäger-Frenkel, 1990, Nandrolone combined with hormone replacement therapy (HRT) and HRT alone in postmenopausal osteoporosis. A comparison of the effects as measured by bone histomorphometry. An interim analysis, 2028 Ott, 1988, Comparisons among methods of measuring bone mass and relationship to severity of vertebral fractures in osteoporosis, J Clin Endocrinol Metab, 66, 501, 10.1210/jcem-66-3-501 Mazess, 1985, The influence of marrow on measurement of trabecular bone using computed tomography, Bone, 6, 349, 10.1016/8756-3282(85)90329-1 Laval-Jeantet, 1986, Influence of vertebral fat on quantitative CT density, Radiology, 159, 463, 10.1148/radiology.159.2.3961178 Christiansen, 1982, Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women, J Clin Endocrinol Metab, 55, 1124, 10.1210/jcem-55-6-1124 Gallagher, 1991, Effect of progestin therapy on cortical and trabecular bone: comparison with estrogens, Am J Med, 90, 171, 10.1016/0002-9343(91)90538-9